Post on 25-May-2018
Biomedical Polymers (Biomaterials) & Biocompatibility
Professors Kinam Park & Luis Solorio
Purdue UniversityBiomedical Engineering
Biomaterials
Biomaterials are basically any non-viable materials which become a part of the body either temporarily or permanently to restore, augment, or replace the natural functions of the living tissues or organs in the body.
They are intended to interact with biological systems.
Applications: prosthetic, diagnostic, and therapeutic.
Drug-Device Combination Products
Ex. antibiotics or growth hormone incorporated into implantable biomaterials for delivery at the implant interface to prevent deep-wound sepsis or to improve wound healing and tissue repair.
Biomaterials
Application of Biomaterials
I. Blood-contacting soft tissue replacements
Heart valve prosthesesMechanical heart valves:
Caged ball or caged disc type: polished CoCr alloy cage and silicone rubber ball, valve sewing ring made of knitted composite of PTFE and polypropylene cloth.Tilting disc type: Pyrolytic carbon disc, guiding struts made of titanium or CoCr.
Bileaflet type: Pyrolytic carbon valvesVascular prostheses: Dacron, PTFE, Silicone rubber
Cardiac pacemakers
Blood oxygenator
Extracorporeal dialysis
Blood circulation tubing
Intravascular catheter
Total artificial heart
http://www.nostalgiacentral.com/tv/drama/sixmillion.htm
Artificial Heart Valves
Examples
Total Artificial Heart
Scientific American
Left Ventricular Assist Device
Artificial Organs
Percutaneous Access Device
Polycarbonate device that allows access to the blood.
Devices are intended for short-term use while on waiting list.
Often on list for extremely long time.
The air port is the main route of infection.
Improved integration with tissue is anticipated to reduce infection.
Material/tissue mechanical property mismatch.
Immortal Human
Transition from Silk to Nylon
Get Your Polymers Here!
1950s: Polymeric Vascular Prostheses-Nylon, Orlon, and Dacron -Orlon and Dacron found to be superiorBoth had high patency rates in large arteries
Bio-glass
One of the first completely synthetic materials used to bind with bone.
Developed in 1967 by Professor Larry Hench.
Was focusing on interactions of glass with radiation.
U.S. Army challenged him to create a material that wouldn’t be rejected by the body, which was costing hundreds of limbs a week in Vietnam.
Created glass with elevated Ca and P ions.
The Filter that Fights Ebola
HemopurifierDeveloped by Aethlon Medical
What makes the Ebola virus so frightening is its speed. In a matter of days, it can pump out enough copies of itself to overtake the immune system. But the Hemopurifier, a specially designed cartridge that attaches to a dialysis machine, can tip the balance back in the body’s favor: its lectin filter attracts Ebola viruses and sucks them from the blood as it flows through. It’s been used only once, on a patient in Germany, but it did the trick—effectively curing his Ebola infection. In the future, doctors hope similar tech could be used on viruses like hepatitis.
http://time.com/3594971/the-25-best-inventions-of-2014/?xid=newsletter-brief
Fast Swelling Hydrogels for Aneurysm Treatment
HydroCoil Embolic System: MicroVention (www.microvent.com/Home/hydrocoil/index.html)
Adhesive Hydrogels as Gastric Bandage
Mucoadhesive hydrogel films to cover the ulcer area.Delivery of blood clotting agents.
CH2 CHC OOH n
http://www.nlm.nih.gov/medlineplus/ency/imagepages/19243.htm
The procedure called gastroscopy involves the placing of an endoscope (a small flexible tube with a camera and light) into the stomach and duodenum to search for abnormalities. Tissue samples may be obtained to check for H. pylori bacteria, a cause of many peptic ulcers. An actively bleeding ulcer may also be cauterized (blood vessels are sealed with a burning tool) during a gastroscopy procedure
Application of Biomaterials
II. Non-blood-contacting soft tissue replacements
Sutures and allied augmentation devicesSutures, Clips, staples, and pins, Surgical tapes, Tissue adhesives
Percutaneous and skin implants: Artificial skin, Burn dressing
Maxillofacial implantsReconstructive surgery: Copolymers of vinyl chloride and vinyl acetate, PMMA, silicone rubber, polyurethane
Ear and eye implants: Contact lens, Intraocular lens
Space-filling implants: Silicone gel breast implants, tissue expanders
Fluid transfer implants: Cerebrospinal fluid shunts, Endotracheal tubes, Urinary catheter, Peritoneal dialysis catheters
Prosthetic joints
Implantable drug delivery devices
Tissue Expander
Manual delayed expansion.Predefined size and shape.No ability to reshape by surgeons.
Current Tissue Expanders: Hydrogels
Copolymers of methylmethacrylate and N-vinylpyrrolidone
Predefined size and shape.No ability to reshape by surgeons.
C C
H
H
CH 3
C O
OCH 3
CH2 CHNO
n
The volume increase of 3-12 folds.
Hydrogel in silicone shell to reduce the swelling speed.
http://www.osmed.biz/html_e/produkte/produkte.html
New Hydrogel Tissue Expanders
A hydrogel expander normal and beingflexed between fingers. Note its elasticity.
http://polyscitech.com/currentResearch/restiex/ Restiex®
Re-Shapable Tissue Expanding Hydrogel
Application of Biomaterials
III. Hard tissue replacements
Bone repair and joint implantsMetallic alloys, biodegradable polymers (PLA, PGA) for treating minimally loaded fractures.
Surgical wiresUsed to reattach large fragments of bone, to provide additional stability in long-oblique or spiral fractures of long bones.
PinsUsed primarily to hold fragments of bones together and to guide large screws during insertion.
ScrewsMost widely used devices for fixation of bone fragments and to attach a metallic plate to bone.
PlatesUsed to facilitate fixation of bone fragment
Intramedullary nailsUsed as internal struts to stabilize long bone fractures.
Joint replacementsHip joint replacements
Dental implants
Polycaprolactone
Approved the use of the device under the emergency-use exemption
written informed consent was provided by the patient’s parents
The splint was manufactured from polycaprolactone
N Engl J Med 368: 21
Tracheal Brace
http://www.engin.umich.edu/college/about/news/stories/2013/may/3d-printed-splint-saves-life#inline_content_2164816
Commonly Found Degradable Biomaterials in FDA Approved Devices
Devices are approved by the FDA
Polymers are not approved by the FDA
Polydioxanone: suture clips and bone pins poly(caprolactone): contraceptives and as a suture Poly(PCPP-SA anhydride): Gliadel Wafer
poly(glycolic acid) (PGA)poly(lactic acid) (PLA)copolymer (PLGA) degradable sutures, bone pins, and drug delivery vehicles
PCL Case Study
PCL can be used for 3D printing to fill in bone defects of the face using 3D images obtained from CT scans to reconstruct a damaged area.
Would PCL be approved to fill in bone defects found in a critical defect of the femur?
Biocompatibility
Biocompatibility
The appropriate biological performance, either local or systemic, of a given implant in a specific application.
Desirable host response depends on the type of materials implanted and their intended use. It may be total inertness and no interaction with tissues surrounding the implanted materials or positive interaction resulting in active participation of the cells surrounding the materials.
Biocompatibility is a dynamic two-way process that involves the time-dependent effects of the host on the material and the material on the host. The performance of a biomaterial should not be affected by the host and the host should not be negatively affected by the implanted biomaterials.
No clear, absolute definition of biocompatibility exists yet mainly due to the fact that the biomaterials area is still evolving.
Potential side effect: Toxic, carcinogenic, immunogenic, and inflammatory responses.
Failure of Biomaterials and Biomedical Devices
1. Tissue Biocompatibility (Inflammation and Wound Healing)
2. Thrombosis (Blood Clotting)
3. Infections
Failure of Biomaterials and Biomedical Devices
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
Preg
nanc
y R
ate
Per
100
Year
Norplant
Biomaterials-Tissue Interactions
Local Interactions(at biomaterial-tissue interface)
Effect of material on host tissues
• Blood material interactions• Modification of healing• Inflammation• Infection• Tumorigenesis
Effect of environment on materialsPhysical-mechanical effects• Wear• Fatigue• Corrosion• Stress-corrosion cracking
Biological Effects• Adsorption of tissue constituents
by implant• Enzymatic degradation• Calcification
Systemic Interactions• Embolization• Hypersensitivity (itchy/redness)• Elevation of implant elements in blood• Particle transport to distal tissues
Device Associated Complications• Thrombosis/thromboembolism• Infection• Exuberant or poor healing• Biomaterial failure• Adverse local tissue reaction• Adverse systemic effect
Host Response to Injury
Placement of a biomaterial in a body requires injuring the host tissues or organs.
Mechanisms are activated to maintain homeostasis.
Injury/Implantation
Blood Material Interactions
Closely linked with inflammation.
Initial response mainly involves blood and vasculature.
Vroman effect-Proteins initially rapidly adsorb onto the surface ~10 μsec.
-Then competitive displacement of earlier adsorbed proteins with a higher affinity for the surface occurs.
-Protein adsorption can alter the protein conformation and overall function.
Blood clot formation and/or thrombus occurs.
Blood/protein deposition on the material constitutes the provisional matrix. http://andrew-white.com/research
Provisional Matrix
Blood/protein deposition on the material constitutes the provisional matrix
Consists of fibrinInflammatory products released by the complement systemActivated plateletsInflammatory cellsEndothelial Cells
Occurs within minutes to hours after implantation
Provides both structural and biochemical components during wound healing
Naturally derived biodegradable controlled release system
Components drive the repair process-inflammatory cell and fibroblast recruitment
Physiological Reviews 2003 Vol. 83 no. 3, 835-870
Inflammation
5 Cardinal Signs of Inflammation During Injury
• Heat
• Redness
• Swelling
• Pain
• Loss of function
Inflammation
The reaction of vascularized living tissue to local injury
• Contain
• Neutralize
• Dilute
• Wall Off Injurious Agent
Changes in the vascular flow and permeability
Exudation-Fluid, proteins, and blood cells escape from the vasculature system into the injured tissue
Followed by cellular events that characterized the inflammatory response
Acute and Chronic Inflammation
Annu. Rev. Mater. Res. 2001. 31:81–110
Acute and Chronic Inflammation
Fig. 8. A typical implanted cage retrieved after 21 days implantation The cage has been cut open and the inner surface is shown. Connective tissue was observed to cover the entire surface area of the mesh cage.
Fundam Appl Toxicol. 1989 Aug;13(2):217-227
Acute and Chronic Inflammation
Fundam Appl Toxicol. 1989 Aug;13(2):217-227
Acute Inflammation
Acute inflammation is of relatively short duration
The main characteristics of acute inflammation are-build up of fluid and proteins-emigration of leukocytes from blood to the injury
Opsonins (IgG) plasma derived proteins that adsorb to biomaterials
The accumulation of leukocytes is the most important feature of the inflammatory reaction
The major role of the neutrophils in acute inflammation is to phagocytose microorganisms and foreign materials
Phagocytosis is a three-step process:-recognition and neutrophil attachment-engulfment-killing or degradation
Biomaterials are not generally phagocytosed by neutrophils or macrophages because of the size disparity
Frustrated phagocytosis- release of leukocyte to degrade the biomaterial without engulfing
The amount of enzyme released depends on the size of the device. Larger particles inducing greater amounts of enzyme release.
Acute and Chronic Inflammation
Annu. Rev. Mater. Res. 2001. 31:81–110
Chronic Inflammation
Chronic inflammation is characterized by the presence of macrophages, monocytes, and lymphocytes, with the proliferation of blood vessels and connective tissue.
Persistent inflammatory stimuli: Chemical, physical, motion.
Confined to the implant site.
Macrophages process and present the antigen to immunocompetent cells and thus are key mediators in the development of immune reactions.
The macrophage is probably the most important cell in chronic inflammation because of the great number of biologically active products it produces.
Growth factors such as PDGF, FGF, TFG-β, TGF-α/EGF, and IL-1 or TNF are important to the growth of fibroblasts and blood vessels and the regeneration of epithelial cells.
Granulation Tissue
Proliferation of fibroblasts and vascular endothelial cells at the implant site, leading to the formation of granulation tissue, the hallmark of healing inflammation.
Pink, soft granular appearance on the surface of healing woundsHistological features include the proliferation of new small blood vessels and fibroblasts.
Fibroblasts synthesize collagen and proteoglycans.Early stages of granulation tissue development, proteoglycans predominate.Later collagen dominates and forms the fibrous capsule.
Observed as early as three to five days following implantation.
Primary Intention-is the healing of a clean, surgical incisions, with a minimal loss of tissue.
Second Intention- occurs when there is a large tissue defect, cannot reconstitute the original architecture (Big Scar).
Histology
Hemotoxylin & Eosin (H&E)
Hemotoxylin: basic dye that stains acidic structures blue
Eosin: acidic dye and stains basic structures red
Most proteins stain pinkNuclei stain purple
Granulation Tissue
Foreign Body Reaction
Composed of foreign body giant cells, macrophages, fibroblasts and capillaries
Surface topography will dictate the extent of the foreign body reaction-smooth surfaces have a foreign body reaction composed of macrophages and foreign body giant cells at the surface.-rough surfaces have foreign body giant cells, macrophages, and granulation tissue sub-adjacent to the surface response.
High surface-to-volume implants have a higher ratio of macrophages and foreign body giant cells at the implant sight, increasing fibrosis.
The foreign body reaction may persist for the entire life of the implant.
Foreign Body Reaction
Fibrosis/Fibrous Encapsulation
Fibrosis surrounds the biomaterial with an interfacial foreign body reaction
Consists of connective tissue
Isolates the biomaterial from the local tissue environment
End stage healing response
Exceptions to the ruleImplant site repair involves 2 processes:
-regeneration, replacement of injured tissue by parenchymal cells of the same type-replacement by connective tissue (fibrous capsule)
Extent of the injury and framework of the tissue (bone vs nervous system) determines process-cells are labile (stem cells), stable (can replicate, but not typical), or permanent (static)-all injuries to permanent cells give rise to fibrosis/loss of tissue function
Fibrosis
Tissue Reaction
Description of fibrous capsule formation around the implanted biomaterial. Activated polymorphonuclearleukocytes (PMN) release enzymes to remove dead cells, and macrophages (Mϕ) participate in the phagocytosis of foreign and cellular debris, Mϕ also stimulate fibroblasts (FB) to secrete collagen and other extracellular matrix components to form a fibrous capsule around the implanted biomaterial.
Discussion
How does the wound healing cascade effect the development of medical devices?
How does it affect the development of controlled release systems?
Thrombosis
Protein Adsorption
Hydrophobic materials:Fast adsorption which is largely irreversibleMost change in protein conformation (reduced bioactivity)
Hydrophilic materials:Slower adsorption, with significant desorption
-Protein exchange Least change in protein conformation (maintains bioactivity)
Proteins with a high surface activity will replace the protein with lower surface activity
Ex: Fibrinogen will replace albumin
Problems Associated With Biomaterials
Surface-induced thrombosis with blood-contacting biomaterials
Blood
Exposure of biomaterial to blood
Protein adsorption
Platelet adhesion: Type of blood proteins
Platelet spreading and platelet activation
Thrombus formation
Thrombus aging and embolization
Short-term surface passivation
Surface-Induced Thrombosis
Platelet adhesion Platelet spreading and platelet activation
Thrombus formation Short-term surface passivation
Glycocalyx
Cells interact with blood constantly, yet do not typically induce a thrombotic event unless there is an injury
Glycocalyx- Glycoprotein, glycolipid, and proteoglycan based covering an one side of the epithelium
Helps to mitigate non-specific protein adsorption
Inhibits cell adhesion
Also found in bacteria, and helps to shield bacteria from the immune response
Prevention of (platelet-activating) protein adsorption
Schematic description of steric repulsion exered by the surface-grafted linear polymers such as poly(ethylene oxide) or heparin (A) and globular proteins such as albumin (B).
Steric repulsion by surface-grafted PEO chains
Fibrinogen adsorption to glass surfaces grafted with various Pluronic® surfactants (L, P, and F series). The control surface was trichlorovinylsilane-modified glass. The three numbers in parentheses indicate the numbers of repeating units of ethylene oxide (EO) and propylene oxide (PO) in the poly(EO)/poly(PO)/poly(EO).
Pluronics®: PEO-PPO-PEO triblock copolymersPEO: poly(ethylene oxide)
PPO: poly(propylene oxide)
Glycocalyx Mimics
Can bind carbohydrates which are found in the glycocalyx to the surface of a material
Can reduce protein binding
Dextran and Maltose among others have been used
Low density coverage- PEG is superior because the conformational variability allows it to spread and cover more defect areas
High density coverage- Carbohydrates are theoretically better, because PEG tends to aggregate at higher concentrations
Challenges and Opportunities
Successful long-term applications of implantable materials requires prevention or minimization of surface-induced thrombosis and/or fibrous encapsulation (or isolation) of implants by the body.
While the surface modification of biomaterials with PEO, heparin, albumin, and other hydrophilic polymers appears to be promising, further systematic studies on the long-term effects of surface modification of biomaterials are necessary for the development of truly biocompatible materials.
Infection
Sterilization vs Sanitation vs Disinfection
Sterilization kills all forms of microbial life (bacteria, spores, fungi, viruses)
Disinfection destroys organisms in a non-sporing vegetative state
Sanitizing reduces organisms on a surface to make them safe for contact
Medical devices need to be sterilized before implantation into human hosts1. Steam (autoclave)2. Ethylene Oxide Vapor3. Gamma Irradiation4. Surface Methods: Ozone, formaldehyde, dry heat, electron radiation
Steam Sterilization
Process: Steam at 125°C at 3 atmospheres
Advantages: Simple and quick (~20 min)EffectiveGreat to use with non-organics, metals, glass
Disadvantages: Not for use with all polymers (can melt or soften them)Poor penetration throughout the polymerMay potentially lead to degradation of the polymer
Ethylene Oxide Sterilziation
Process: Pre-conditioning of sampleGassing/exposureEvacuationAeration (air wash)
Advantages: Can be used with many polymersMany places provide the service
Disadvantages: Ethylene Oxide is toxic and potentially explosiveCan react with carboxylic acids, alcohols, and aminesNeed to ensure complete removal of the residual gasNeed to optimize the conditions
Gamma Radiation
Process: Transmission of energy by EM waves that breaks DNA strandsSterilization is proportional to the amount of radiation absorbed1 Rad= 100 erg= 1x105 Joules absorbed energy/ gram of materialγ rays have the highest penetration in air
Advantages: No residual radiationCan use the sample immediatelyLow temperatures can be usedHigh penetration of the device
Disadvantages: Often times initiates degradation of polymer (changes the molecular weight)Can initiate crosslinkingsNeed special equipment and safety precautions
Cyclodextrin Coated Materials
Creates a pocket for hydrophobic drugs or antibiotics
Drug is not bound to the pocket and can be replaced by another hydrophobic molecule or another drug molecule
Hydrophobic compounds can hop from pocket to pocket
Cyclodextrin Coated Materials
http://dx.doi.org/10.1016/j.jss.2010.03.065
Cyclodextrin Coated Materials
Biomaterials 31 (8) 2010: 2335–2347
Commonly Found Degradable Biomaterials in FDA Approved Devices
Devices are approved by the FDA
Polymers are not approved by the FDA Polydioxanone: suture clips and bone pins poly(caprolactone): contraceptives and as a suture Poly(PCPP-SA anhydride): Gliadel Wafer
poly(glycolic acid) (PGA)poly(lactic acid) (PLA)copolymer (PLGA) degradable sutures, bone pins, and drug delivery vehicles
Rates of Degradation
Polyanhydrides degrade very quickly and are typically in surface eroding materials .
Polyesters degrade slower than polyanhydrides and the rate of water uptake is faster than the rate of polymer degradation so these devices tend to be bulk eroding devices.
Polyamides degrade even slower and are bulk eroding.
In order to create a device that was surface eroding for a polyester it would have to be 7.4 cm thick and a polyamide would need to be 13.4 m thick.
Polymer Degradation Products
PLGA degrades into both lactic and/or glycolic acid.
In healthy tissues with high clearance, these intermediates are metabolized by the body into carbon dioxide and water and show no adverse effects upon introduction of the material to the body.
If the clearance is low, elevated levels of acidic byproducts can accumulate in the tissue space.
It is important to make sure that the degradation products are not toxic.
Additives
Additives are used to modify an implant’s properties and to reduce manufacturing cost.
fillers and plasticizers are typically used to alter the mechanical properties.
Plasticizer di(2-ethylhexyl)phthalate (DEHP) has been used to soften the poly(vinyl chloride) used in blood storage bags.
-DEHP can damage the liver, kidneys, lungs, and reproductive system, particularly the developing testes of prenatal and neonatal males.
Plasticizers typically increase the flexibility of the plastic by disrupting the crystallinity.
However the effect of additives used must be carefully evaluated to insure that the additive does not induce a negative effect.
ISO10993
The ISO 10,993 standard and the FDA guidance document present a structured program for biocompatibility evaluation in which matrices are presented that indicate required tests according to specific types of tissue contact and contact duration.
CytotoxicitySensitizationHemocompatibilityPyrogenicityImplantationGenotoxicityCarcinogenicityReproductive and Developmental ToxicityDegradation Assessments